Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

254
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
03/20/2015 03/23/2015 03/24/2015 03/25/2015 03/26/2015 Date
274.9(c) 273.9(c) 271.5(c) 268.8(c) 263.9(c) Last
3 624 245 1 370 277 1 353 248 1 415 113 1 773 065 Volume
+0.95% -0.36% -0.88% -0.99% -1.82% Change
More quotes
Financials ( CHF)
Sales 2015 46 685 M
EBIT 2015 16 618 M
Net income 2015 11 371 M
Debt 2015 8 635 M
Yield 2015 3,09%
Sales 2016 48 659 M
EBIT 2016 17 738 M
Net income 2016 12 408 M
Debt 2016 4 322 M
Yield 2016 3,26%
PER 2015 20,48
PER 2016 18,85
EV / Sales 2015 5,14x
EV / Sales 2016 4,84x
Capitalization 231 409 M
More Financials
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
04/02Shareholder meeting
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
03/22 Currency hedging takes on new importance for global stock funds
03/19 ROCHE : Sigma-Aldrich : Announces Exclusive Distribution Agreement with Roche
03/12DJ23andMe to Use Genetic Database for Drug Discovery
03/05DJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 4th Update
03/05DJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 3rd Update
03/05 ROCHE HOLDING LTD. : ex-dividend day for annual dividend
03/03 ROCHE : Global scientific collaborators to explore latest pathology and oncology..
02/25 Biosimilar copies of blockbuster drug launch in major EU markets
More news
Sector news : Pharmaceuticals - NEC
11:23p ROCHE BEARER SHARE : Drug manufacturer Genentech to expand Hillsboro operations
09:54p CELGENE : MorphoSys And Celgene Agree To End MOR202 Collaboration
05:05pDJREGENERON PHARMACEUTICALS : Correction to Headline on Wednesday's Regeneron Stor..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06:01p 3 BIOTECHS THAT COULD CHANGE MEDICIN : Wasatch Analyst Jill Wahleithner
03/24 Pacific Biosciences Still Trying To Claw Out Its Own Niche
03/24 IMMUNOGEN : Investors Shouldn't Read Too Much Into The Takeda Deal
03/24 How Big Will The Biotech Bubble Get?
03/23 Pfenex to receive $51M payment from Hospira for Lucentis biosimilar


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF